FBIOP
Fortress Biotech, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Lindsay Allan Rosenwald
IPO Date
2017-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Fortress Biotech, Inc.
CEO
Lindsay Allan Rosenwald
IPO Date
2017-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 6,666 |
| $0.00 |
| 3 Jan 2024 | Lorenz Kevin | director | A-Award | Acquired | 3,333 | $0.00 |
| 3 Jan 2024 | ROSENWALD LINDSAY A MD | director, 10 percent owner, officer: President, CEO & Chairman | A-Award | Acquired | 216,465 | $0.00 |
| 3 Jan 2024 | Lu Lucy | director | A-Award | Acquired | 3,333 | $0.00 |
| 3 Jan 2024 | Harvey Jimmie | director | A-Award | Acquired | 6,666 | $0.00 |
| 3 Jan 2024 | LOBELL J JAY | director | A-Award | Acquired | 6,666 | $0.00 |
| 3 Jan 2024 | Hoenlein Malcolm | director | A-Award | Acquired | 3,333 | $0.00 |
| 3 Jan 2024 | Rowinsky Eric K | director | A-Award | Acquired | 6,666 | $0.00 |
| 3 Jan 2024 | WEISS MICHAEL S | director, 10 percent owner, officer: See Remarks | A-Award | Acquired | 216,465 | $0.00 |